High Throughput Screening Market

The High Throughput Screening (HTS) market consists of automated methods used to rapidly test the biological or biochemical activity of a large number of chemical compounds. Its primary customers are pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations (CROs). Key growth drivers include the pressing need to accelerate early-stage drug discovery and the integration of artificial intelligence and machine learning to improve the predictive power and efficiency of screening platforms.